{"id":"W2027545702","doi":"10.1056/nejmoa020047","title":"Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection","year":2002,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Hepatitis C virus research","field":"Medicine","cited_by":6397,"is_retracted":false,"has_abstract":true,"ca_institutions":"Nutrasource","funders":"National Center for Research Resources","keywords":"Ribavirin; Medicine; Peginterferon alfa-2a; Internal medicine; Gastroenterology; Interferon alfa; Alpha interferon; Hepatitis C; Hepatitis C virus; Placebo; Interferon; Immunology; Virus; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008858002,0.0004173788,0.0008007166,0.0002901835,0.0004021981,0.0002104528,0.0002297254,0.0003897496,0.003040687],"category_scores_gemma":[0.001078971,0.0001547377,0.0003473364,0.000313836,0.0002330085,0.0002069921,0.0002236007,0.0005242302,0.0003967537],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003080281,"about_ca_system_score_gemma":0.000569651,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003548537,"about_ca_topic_score_gemma":0.0005899348,"domain_scores_codex":[0.9995876,0.0001834774,0.00004889417,0.00005202921,0.00007190912,0.00005623215],"domain_scores_gemma":[0.999517,0.0001642844,0.00008304615,0.0000212318,0.00002983441,0.0001847081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2232456,0.009757536,0.1869592,0.00251444,0.001359095,0.0009042445,0.0002839451,0.001883563,0.02656214,0.0003535604,0.006566272,0.5396104],"study_design_scores_gemma":[0.1307212,0.2382174,0.5843196,0.0007177522,0.001327319,0.006761887,0.0002002704,0.002542027,0.005773509,0.0005602461,0.02879555,0.00006325053],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9881964,0.007960836,0.0003809729,0.0005202764,0.0001587317,0.0008006645,0.0002312415,0.00002367885,0.001727218],"genre_scores_gemma":[0.9936743,0.002938162,0.0008748611,0.0004837807,0.000262947,0.0005790613,0.0003611679,0.000003265305,0.000822415],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003040687,"threshold_uncertainty_score":0.01017219,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06331394442343537,"score_gpt":0.3399126845956345,"score_spread":0.2765987401721992,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}